Questions from Deputy Ken O'Flynn - PQ 36602-26, 36605-26, 36608-26, 36609-26, 36390-26, 36391-26 and 37080-26
Deputy O'Flynn asked about gender-related healthcare services. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about gender-related healthcare services. Read the HSE response.
Deputy O'Flynn asked about the guidance issued by the HSE to individuals in areas where manganese levels exceed 50 µg/l. Read the HSE response.
Deputy O'Flynn asked if any cases of adverse health outcomes linked to manganese exposure in drinking water have been reported. Read the HSE response.
Deputy O'Flynn asked if any complaints or appeals were received from pharmacies regarding claim rejection accuracy or consistency. Read the HSE response.
Deputy O'Flynn asked if pharmacies or representative bodies are formally consulted before changes to reimbursement rules. Read the HSE response.
Deputy O'Flynn asked if the HSE has considered introducing additional automated pre-submission validation systems to reduce pharmacy claim rejection rates.
Deputy O'Flynn asked about standardised criteria when assessing treatment under the Treatment Abroad Scheme. Read the HSE response.
Deputy Callaghan asked about the cancer genetics department in St. James's Hospital. Read the HSE response.
Deputy O'Flynn asked about the reducing the number of rejected or unpaid pharmacy claims attributable to administrative or submission errors.
Deputy Sherlock asked about the steps being taken to improve access to LGBTQ+ affirming mental health supports. Read the HSE response.